Scientists in Russians and Sweden laboratories have discovered a new substance that would create cheaper and more effective drugs against allergy and cancer.
Lately, we have heard of adjuvants, substances that make vaccines more effective, because the Spanish government has decided to administer to pregnant influenza vaccines without adjuvants. And we may have to take account of it in the future, because they can be the key to important treatments.
Many of the treatments developed today against allergies, cancer and autoimmune diseases are based on monoclonal antibodies. But they have a very high cost and should be used for a long time.
Therapeutic vaccines do not contain antibodies (Iga, IgM, IgG), but stimulate our body to produce and that are cheaper than most medications. But they have a problem: the absence of adjuvants, substances that make them more effective.
Because until now, there was only an adjuvant approved for use in people, which also is very inefficient when faced with molecules produced by the body itself.
To resolve this problem, Russian scientists worked together with their Sweden’s colleagues and it seems they got a good result.
They have made a breakthrough by identifying a substance that is biologically degradable and which shows a much higher activity for adjuvants that have been used in the past, explains Lars Hellman, director of the research.
This new adjuvant may be the key to cheaper and more effective treatments for allergic and cancer.
